de Waard, E. A. C. http://orcid.org/0000-0002-1483-3156
de Jong, J. J. A.
Koster, A.
Savelberg, H. H. C. M.
van Geel, T. A.
Houben, A. J. H. M.
Schram, M. T.
Dagnelie, P. C.
van der Kallen, C. J.
Sep, S. J. S.
Stehouwer, C. D. A.
Schaper, N. C.
Berendschot, T. T. J. M.
Schouten, J. S. A. G.
Geusens, P. P. M. M.
van den Bergh, J. P. W.
Funding for this research was provided by:
European Regional Development Fund
the Province of Limburg
the Dutch Ministry of Economic Affairs (31O.041)
Stichting de Weijerhorst
the Pearl String Initiative Diabetes
the Cardiovascular Center Maastricht
Cardiovascular Research Institute
School for Public Health and Primary Care
School for Nutrition, Toxicology and Metabolis
Health Foundation Limburg
Janssen-Cilag B.V.
Novo Nordisk Farma B.V.
Sanofi-Aventis Netherlands B.V.
Article History
Received: 30 June 2017
Accepted: 19 August 2018
First Online: 13 September 2018
Compliance with ethical standards
: The study has been approved by the institutional medical ethical committee (NL31329.068.10) and the Minister of Health, Welfare and Sports of the Netherlands (Permit 131088-105234-PG). All participants gave written informed consent.
: None.